Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

rRp450-Phase I Trial in Liver Metastases and Primary Liver Tumors

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Kenneth K. Tanabe, MD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01071941
First received: January 13, 2010
Last updated: September 13, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2017
  Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)